| Literature DB >> 30777069 |
Mengruo Zhu1,2, Haiyan Chen1, Zibire Fulati1, Yang Liu1, Yangang Su2, Xianhong Shu3,4.
Abstract
BACKGROUND: Three-dimensional (3D) speckle tracking imaging (STI) allows the simultaneous assessment of left ventricular (LV) strain and volume. We aim to explore the value of LV strain-volume loops in predicting response to cardiac resynchronization therapy (CRT).Entities:
Keywords: Cardiac resynchronization therapy; Heart failure; Segmental heterogeneity; Strain–volume loop; Wasted septal work
Year: 2019 PMID: 30777069 PMCID: PMC6379938 DOI: 10.1186/s12947-019-0153-3
Source DB: PubMed Journal: Cardiovasc Ultrasound ISSN: 1476-7120 Impact factor: 2.062
Fig. 1Three-dimensional speckle-tracking imaging of individual examples from a CRT responder and a non-reponder before CRT and 6-month follow-up after CRT. (a) A CRT responder before CRT; (b) A CRT responder at 6-month follow-up after CRT; (c) A CRT non-responder before CRT; (d) A CRT non-responder at 6-month follow-up after CRT. The image upper right is 16 segmental strain-time curves and lower right is 16 segmental volume-time curves
Fig. 2Strain–volume loops and the linear fitting curves of individual examples from a healthy subject, a CRT responder and a non-responder at baseline and follow-up. (a) Global strain–Global volume loop; (b) Segmental (Midseptal and Midlateral) strain–Global volume loop; (c) Midseptal strain–Midseptal volume loop and Midlateral strain–Midlateral volume loop
Fig. 3Bland-Altman analysis for inter-observer variability and inter-observer variability of all three-dimensional (3D) speckle-tracking imaging measures. (a) Inter-variability of conventional 3D echocardiographic parameters; (b) Intra-variability of conventional 3D echocardiographic parameters; (c) Inter-variability of segmental peak strain and characteristics of strain-volume loops; (d) Intra-variability of segmental peak strain and characteristics of strain-volume loops. LVEDV, left ventricular end-diastolic volume; LVEF, left ventricular ejection fraction; LVESV, left ventricular end-systolic volume; GCS, global circumferential strain; GLS, global longitudinal strain; PS, principal strain; SDI, strain delay index; Tmsv-SD%, standard deviation of time to minimum systolic volume corrected by R-R interval; TpPS-SD%, standard deviation of time to peak principal strain corrected by R-R interval
Baseline clinical characteristics of CRT responders versus non-responders
| Variable | Responders | Non-Responders | |
|---|---|---|---|
| ( | ( | ||
| Age, years | 61.5 ± 10 | 58.2 ± 15.2 | .444 |
| Female gender, | 9 (33%) | 1 (8%) | .113 |
| Heart rate, beats/min | 73.5 ± 11.5 | 79.6 ± 23.1 | .407 |
| SBP, mm Hg | 121.8 ± 13 | 115.8 ± 18.6 | .273 |
| DBP, mm Hg | 76 ± 8.3 | 70.5 ± 7.4 | .065 |
| NYHA functional class III/IV | 23/4 | 8/5 | .685 |
| Ischemic Etiology, | 7 (26%) | 5 (38%) | .709 |
| QRS | |||
| duration (ms) | 160.5 ± 24.1 | 158.3 ± 28.5 | .812 |
| LBBB morphology, | 20 (74%) | 9 (69%) | .706 |
| Mitral regurgitation > grade II, | 15 (56%) | 9 (77%) | .463 |
| Hypertension, | 14 (52%) | 3 (23%) | .163 |
| Diabetes, | 6 (22%) | 2 (15%) | 1.000 |
| Renal insufficiency, | 3 (11%) | 1 (8%) | 1.000 |
| Serum biomarkers | |||
| CK-MB, U/L | 11.5 ± 4.07 | 10.83 ± 3.69 | .646 |
| CK-MM, U/L | 53.4 ± 30.13 | 54 ± 31.79 | .958 |
| Cre, μmol/L | 84.74 ± 41.04 | 88.62 ± 15.48 | .756 |
| hs CRP, mg/L | 7.46 ± 15.96 | 3.27 ± 6.2 | .513 |
| Uric acid, μmol/L | 425.44 ± 148.55 | 479.03 ± 168.72 | .340 |
| NT-proBNP, pg/mL | 2684.83 ± 2658.35 | 2956.5 ± 2748.22 | .786 |
| cTnT, ng/mL | 0.02 ± 0.02 | 0.03 ± 0.02 | .101 |
| Medication, | |||
| ACEI/ARBs | 15 (55%) | 7 (54%) | 1.000 |
| Beta-blockers | 13 (48%) | 6 (46%) | 1.000 |
| Diuretics and/or spironolactone | 13 (48%) | 6 (46%) | 1.000 |
ACEI Angiotensin converting enzyme inhibitor, ARB Angiotensin receptor blocker, CK-MB Creatine kinase MB fraction, CK-MM Creatine kinase MM fraction, Cre Creatinine, cTnT Cardiac troponin T, DBP Diastolic blood pressure, hs CRP High sensitive C-reactive protein, LBBB Left bundle branch block, NT-proBNP N-terminal of the prohormone brain natriuretic peptide, NYHA New York Heart Association, SBP Systolic blood pressure
Data are expressed as number (percentage) or mean ± SD
Comparisons of 2D and 3D echocardiographic characteristics
| Variable | Controls | All Patients |
| Baseline | Follow-up | Baseline versus Follow-up | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Responders | Non-responders |
| Responders | Non-Responders |
| ||||||
| ( | ( | ( | ( | Value | ( | (n = 13) | Value | Responders | Non-responders | ||
| 2D Echocardiographic Parameters | |||||||||||
| Aortic root, mm | 30.2 ± 2.7 | 33.9 ± 4.2 | .001 | 34.4 ± 4.4 | 32.9 ± 3.7 | .329 | 35.1 ± 5 | 32.9 ± 3.5 | .206 | .214 | 1.000 |
| LA, mm | 34.2 ± 2.9 | 47.1 ± 10.7 | .000 | 44.7 ± 11.6 | 51.9 ± 6.6 | .054 | 41.6 ± 5.6 | 48.9 ± 7.2 | .002 | .121 | .200 |
| LVEDD, mm | 46.3 ± 5.1 | 68.9 ± 14.4 | .000 | 68.8 ± 7.4 | 69.2 ± 23.1 | .942 | 64 ± 10.1 | 75.8 ± 8.6 | .002 | .000 | .392 |
| LVESD, mm | 28.7 ± 3.0 | 60.2 ± 8.8 | .000 | 58 ± 7.7 | 64.3 ± 9.6 | .042 | 51.1 ± 11.5 | 64.8 ± 9.2 | .001 | .000 | .759 |
| IVS, mm | 8.5 ± 1.0 | 9.0 ± 1.4 | .184 | 9 ± 1.5 | 8.8 ± 1.4 | .685 | 9.6 ± 1.3 | 8.6 ± 1.4 | .042 | .094 | .536 |
| LVPW, mm | 9.1 ± 0.8 | 9.3 ± 1.3 | .419 | 9.3 ± 1.4 | 9.3 ± 1.3 | .880 | 9.5 ± 1 | 8.9 ± 1.2 | .137 | .497 | .137 |
| PASP, mm Hg | 30 ± 2.8 | 43.1 ± 15.8 | .000 | 43.7 ± 14.7 | 47.1 ± 18.5 | .574 | 32.3 ± 5.7 | 37.7 ± 9.7 | .050 | .001 | .130 |
| DT, ms | 168.8 ± 26.9 | 176.2 ± 52.5 | .494 | 173.9 ± 51 | 160.6 ± 80.8 | .619 | 188.3 ± 45.4 | 147.2 ± 44.6 | .028 | .355 | .613 |
| S′ wave, cm/s | 11.7 ± 2.2 | 5.8 ± 1.9 | .000 | 6.1 ± 1.8 | 5.2 ± 1.9 | .201 | 6.2 ± 1.6 | 4.5 ± 1.2 | .003 | .335 | .126 |
| 3D Echocardiographic Parameters | |||||||||||
| LVEDV, mL | 59.5 ± 12.9 | 226.7 ± 95.8 | .000 | 203.5 ± 78.7 | 271.2 ± 112.5 | .045 | 151.5 ± 72.9 | 269.3 ± 106.5 | .000 | .000 | .898 |
| LVESV, mL | 22.2 ± 7 | 179.8 ± 89.4 | .000 | 158.7 ± 77.8 | 220.3 ± 99.3 | .051 | 103.8 ± 61.7 | 208.9 ± 84.6 | .000 | .000 | .458 |
| LVEF, % | 62.9 ± 7.9 | 22.9 ± 9.6 | .000 | 24.4 ± 10.3 | 20 ± 7.7 | .195 | 34.1 ± 8.5 | 22.9 ± 7.7 | .001 | .000 | .165 |
| LV Mass, g | 102.4 ± 18.8 | 239 ± 80.1 | .000 | 229.1 ± 61.3 | 258 ± 108.3 | .317 | 184.7 ± 61 | 279.3 ± 117 | .003 | .000 | .049 |
| GLS, % | − 22.16 ± 4.33 | −7.16 ± 3.38 | .000 | −7.89 ± 3.45 | −5.77 ± 2.86 | .077 | −11.09 ± 2.67 | −7.61 ± 3.47 | .002 | .000 | .088 |
| GCS, % | −30.59 ± 6.8 | −8.64 ± 4.42 | .000 | −9.22 ± 4.98 | −7.53 ± 2.97 | .291 | − 13.41 ± 4.71 | − 8.62 ± 3.33 | .004 | .000 | .103 |
| Twist, ° | 15.63 ± 8.1 | 5.48 ± 5.9 | .000 | 5.76 ± 6.94 | 4.89 ± 2.91 | .695 | 5.64 ± 5.7 | 2.78 ± 3.53 | .123 | .942 | .103 |
| Torsion, °/cm | 2.16 ± 1.19 | 0.59 ± 0.64 | .000 | 0.63 ± 0.76 | 0.51 ± 0.31 | .619 | 0.66 ± 0.68 | 0.28 ± 0.32 | .079 | .857 | .094 |
| SDI, % | −25.52 ± 20.9 | − 33.44 ± 25.53 | .253 | −37.33 ± 28.56 | −25.99 ± 17.07 | .217 | −35.48 ± 32.57 | −20.95 ± 21.4 | .173 | .809 | .468 |
| Mechanical Dyssynchrony Indices | |||||||||||
| TpPS-SD%, % | 6.42 ± 2.57 | 11.73 ± 6.58 | .000 | 11.2 ± 6.22 | 12.73 ± 7.4 | .522 | 8.9 ± 3.26 | 10.15 ± 3.83 | .317 | .030 | .320 |
| Tmsv-SD%, % | 5.71 ± 1.3 | 11.74 ± 6.01 | .000 | 11.95 ± 5.7 | 11.33 ± 6.82 | .775 | 8.89 ± 3.8 | 10.04 ± 3.88 | .405 | .004 | .555 |
DT Deceleration time, IVSd Interventricular septum diastole, LA Left atrial, LVEDD Left ventricular end-diastolic diameter, LVEDV Left ventricular end-diastolic volume, LVEF Left ventricular ejection fraction, LVESD Left ventricular end-systolic diameter, LVESV Left ventricular end-systolic volume, LVPWd Left ventricular posterior wall diastole, GCS Global circumferential strain, GLS Global longitudinal strain, PASP Pulmonary artery systolic pressure, PS Principal strain, SDI Strain delay index, Tmsv-SD% Standard deviation of time to minimum systolic volume corrected by R-R interval, TpPS-SD% Standard deviation of time to peak principal strain corrected by R-R interval
Data are expressed as number (percentage) or mean ± SD
Comparisons of peak strain and characteristics of strain-volume loops
| Variable | Controls | All Patients |
| Baseline | Follow-up | Baseline versus Follow-up | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Responders | Non-responders |
| Responders | Non-Responders |
| ||||||
| Segmental peak strain | |||||||||||
| MidLateral PSPeak | −38.6 ± 11.5 | −14.7 ± 7.3 | .000 | −17.1 ± 7 | −10.1 ± 5.7 | .005 | −20.8 ± 6.6 | −13.2 ± 5.8 | .002 | .030 | .239 |
| MidSeptal PSPeak | −51.6 ± 10.1 | −12.5 ± 8 | .000 | −13 ± 8.8 | −11.6 ± 6.5 | .635 | −22 ± 11 | − 12.4 ± 7.8 | .011 | .001 | .779 |
| Characteristics of strain-volume loops | |||||||||||
| Global PS-Global volume loop | |||||||||||
| slope | 1.08 ± 0.35 | 0.26 ± 0.11 | .000 | 0.29 ± 0.11 | 0.21 ± 0.1 | .062 | 0.43 ± 0.19 | 0.23 ± 0.1 | .002 | .001 | .437 |
| R2-S/D coupling | 0.99 ± 0.01 | 0.97 ± 0.05 | .016 | 0.97 ± 0.05 | 0.96 ± 0.06 | .441 | 0.99 ± 0.02 | 0.98 ± 0.02 | .765 | .055 | .100 |
| Segmental PS-Global volume loop | |||||||||||
| MidLateral PS-Global volume loop | |||||||||||
| slope | 1.06 ± 0.4 | 0.32 ± 0.18 | .000 | 0.38 ± 0.17 | 0.19 ± 0.12 | .001 | 0.45 ± 0.22 | 0.23 ± 0.11 | .003 | .172 | .235 |
| R2-S/D coupling | 0.91 ± 0.08 | 0.79 ± 0.27 | .019 | 0.84 ± 0.22 | 0.69 ± 0.34 | .180 | 0.85 ± 0.15 | 0.83 ± 0.25 | .839 | .920 | .262 |
| MidSeptal PS-Global volume loop | |||||||||||
| slope | 1.46 ± 0.57 | 0.19 ± 0.24 | .000 | 0.2 ± 0.2 | 0.18 ± 0.3 | .782 | 0.48 ± 0.34 | 0.21 ± 0.18 | .004 | .001 | .717 |
| R2-S/D coupling | 0.93 ± 0.04 | 0.54 ± 0.37 | .000 | 0.44 ± 0.39 | 0.73 ± 0.26 | .014 | 0.71 ± 0.29 | 0.66 ± 0.34 | .680 | .002 | .636 |
| Segmental PS-Segmental volume loop | |||||||||||
| MidLateral PS-MidLateral volume loop | |||||||||||
| slope | 18.66 ± 7.41 | 3.85 ± 1.81 | .000 | 4.39 ± 1.78 | 2.82 ± 1.44 | .013 | 6.11 ± 2.88 | 3.21 ± 1.52 | .000 | .004 | .184 |
| R2-S/D coupling | 0.97 ± 0.04 | 0.93 ± 0.11 | .149 | 0.95 ± 0.09 | 0.89 ± 0.15 | .119 | 0.95 ± 0.08 | 0.89 ± 0.18 | .194 | .864 | .991 |
| MidSeptal PS-MidSeptal volume loop | |||||||||||
| slope | 28.26 ± 10.34 | 6.05 ± 3.1 | .000 | 6.67 ± 3.44 | 4.85 ± 1.93 | .099 | 10.8 ± 7.22 | 4.83 ± 2.83 | .002 | .005 | .987 |
| R2-S/D coupling | 0.96 ± 0.06 | 0.91 ± 0.1 | .052 | 0.89 ± 0.12 | 0.94 ± 0.06 | .108 | 0.93 ± 0.13 | 0.81 ± 0.33 | .269 | .353 | .215 |
PS Principal strain
Data are expressed as mean ± SD
Comparison of peak strain and characteristics of strain-volume loops between MidLateral and MidSeptal
| Variable | Controls ( | Baseline | Follow-up | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Responders ( | Non-Responders ( | Responders ( | Non-Responders ( | ||||||||||||
| MidLateral | MidSeptal |
| MidLateral | MidSeptal |
| MidLateral | MidSeptal |
| MidLateral | MidSeptal |
| MidLateral | MidSeptal |
| |
| Segmental PSPeak | −38.6 ± 11.5 | −51.6 ± 10.1 | .000 | −17.1 ± 7 | −13 ± 8.8 | .077 | −10.1 ± 5.7 | −11.6 ± 6.5 | .392 | −20.8 ± 6.6 | −22 ± 11 | .621 | −13.2 ± 5.8 | −12.4 ± 7.8 | .701 |
| Characteristics of strain-volume loops | |||||||||||||||
| Segmental PS-Global volume loop | |||||||||||||||
| slope | 1.06 ± 0.4 | 1.46 ± 0.57 | .002 | 0.38 ± 0.17 | 0.2 ± 0.2 | .002 | 0.19 ± 0.12 | 0.18 ± 0.3 | .887 | 0.45 ± 0.22 | 0.48 ± 0.34 | .469 | 0.23 ± 0.11 | 0.21 ± 0.18 | .646 |
| R2-S/D coupling | 0.91 ± 0.08 | 0.93 ± 0.04 | .373 | 0.84 ± 0.22 | 0.44 ± 0.39 | .000 | 0.69 ± 0.34 | 0.73 ± 0.26 | .721 | 0.85 ± 0.15 | 0.71 ± 0.29 | .025 | 0.83 ± 0.25 | 0.66 ± 0.34 | .203 |
| Segmental PS-Segmental volume loop | |||||||||||||||
| slope | 18.66 ± 7.41 | 28.26 ± 10.34 | .000 | 4.39 ± 1.78 | 6.67 ± 3.44 | .000 | 2.82 ± 1.44 | 4.85 ± 1.93 | .000 | 6.13 ± 2.94 | 10.8 ± 7.22 | .001 | 3.21 ± 1.52 | 4.83 ± 2.83 | .040 |
| R2-S/D coupling | 0.97 ± 0.04 | 0.96 ± 0.06 | .446 | 0.95 ± 0.09 | 0.89 ± 0.12 | .078 | 0.89 ± 0.15 | 0.94 ± 0.06 | .241 | 0.95 ± 0.08 | 0.93 ± 0.13 | .512 | 0.89 ± 0.18 | 0.81 ± 0.33 | .520 |
PS Principal strain
Data are expressed as mean ± SD
Analyses to identify baseline predictors of response to CRT
| Variable | Univariate Analysis | Multivariate Analysis | ||||
|---|---|---|---|---|---|---|
| OR | 95% CI |
| OR | 95% CI |
| |
| Age | 1.011 | 1.000–1.023 | .054 | |||
| Female | 7.071 | 0.774–64.575 | .083 | |||
| QRS duration | 1.004 | 0.976–1.032 | .806 | |||
| LBBB | 1.417 | 0.310–6.470 | .653 | |||
| NYHA class III | 1.800 | 0.380–8.535 | .459 | |||
| Nonischemic Etiology | 1.633 | 0.383–6.968 | .508 | |||
| NT-proBNP | 1.006 | 0.990–1.020 | .340 | |||
| hs CRP | 1.001 | 1.000–1.070 | .420 | |||
| LVESD | 1.009 | 0.998–1.020 | .123 | |||
| LVEDV | 1.001 | 0.999–1.004 | .330 | |||
| LVEF | 1.003 | 0.930–1.082 | .939 | |||
| GLS | 0.892 | 0.809–0.984 | .022 | 0.820 | 0.490–0.995 | .190 |
| GCS | 0.922 | 0.852–0.997 | .042 | 0.962 | 0.657–1.000 | .660 |
| TpPS-SD% | 1.006 | 0.999–1.013 | .112 | |||
| Tmsv-SD% | 1.007 | 1.002–1.015 | .048 | 1.002 | 1.000–1.001 | .120 |
| SDI | 0.978 | 0.958–0.999 | .041 | 0.990 | 0.680–1.000 | .240 |
| MidLateral PSPeak | 0.818 | 0.697–0.960 | .014 | 0.890 | 0.550–0.980 | .150 |
| Slope of MidLateral PS- Global volume loop | 3.934 | 2.863–6.444 | .016 | 2.880 | 1.230–6.700 | .470 |
| R2-S/D coupling of MidSeptal PS-Global volume loop | 0.803 | 0.760–0.880 | .009 | 0.878 | 0.810–0.930 | .028 |
| Slope of MidLateral PS-MidLateral volume loop | 2.035 | 1.104–3.750 | .023 | 1.796 | 0.980–3.000 | .200 |
CI Confidence interval, GCS Global circumferential strain, GLS Global longitudinal strain, hs CRP High sensitive C-reactive protein, LVEDV Left ventricular end-diastolic volume, LVESD Left ventricular end-systolic diameter, NT-proBNP N-terminal of the prohormone brain natriuretic peptide, OR Odd ratio, PS Principal strain, SDI Strain delay index, Tmsv-SD% Standard deviation of time to minimum systolic volume corrected by R-R interval, TpPS-SD% Standard deviation of time to peak principal strain corrected by R-R interval
Fig. 4Receiver operating characteristic (ROC) curves for predicting response to cardiac resynchronization therapy (CRT). The area under the ROC curve (AUC) of R2-S/D coupling of Midseptal PS–Global volume loop was greater than that of TpPS-SD%, Tmsv-SD% and SDI (P < 0.05). SDI, strain delay index; Tmsv-SD%, standard deviation of time to minimum systolic volume corrected by R-R interval; TpPS-SD%, standard deviation of time to peak principal strain corrected by R-R interval
Fig. 5Correlation between percentage change in LVESV (△LVESV%) at 6-month follow-up and baseline R2-S/D coupling of Midseptal PS–Global volume loop